J Bacteriol Virol.  2003 Dec;33(4):317-327.

The Profiles of Plasma Chemokines Following Unrelated Allogeneic Bone Marrow Transplantation and Their Relationship to Transplant-Related Complications

Affiliations
  • 1Department of Microbiology and Immunology, Seoul National University College of Medicine, 28 Yongondong, Chongno-gu, Seoul 110-799, Korea. myung@snu.ac.kr
  • 2Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Pungnap-dong, Sonpa-gu, Seoul138-736, Korea.
  • 3Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Pungnap-dong, Sonpa-gu, Seoul138-736, Korea.

Abstract

Chemokines are a family of closely related chemotactic cytokines known to be potent attractors for various leukocyte subsets such as neutrophils, monocytes, or lymphocytes. We investigated the chemokine profiles in 26 patients who received unrelated allogeneic bone marrow transplantation (BMT) and evaluated the relationship of chemokines to transplant-related complications. We measured plasma levels of regulated upon activation normal T-cell expressed and secreted (RANTES), macrophage inflammatory protein-1alpha (MIP-1alpha), macrophage inflammatory protein-1beta (MIP-1beta), and interleukin-8 (IL-8) at BMT day -7, day 0, and day 21. When compared with preBMT levels, the mean level of RANTES was significantly decreased at day 21, and the mean level of IL-8 was significantly elevated at day 21. Methotrexate given for graft-versus-host disease (GVHD) prophylaxis and postBMT infectious complication respectively may have contributed to these plasma chemokine level changes. The mean level of IL-8 was significantly higher in patients with infectious complications at day 21 (p=0.009). However, plasma chemokine levels were not associated with the development of acute GVHD and veno-occlusive disease (VOD). Since chemokine production acts in a local manner, plasma levels may not reflect the actual activity of chemokines in target tissue. Further experimental and clinical studies, including chemokine expression in target tissue, are warranted to define the roles of chemokines following allogeneic BMT.

Keyword

Chemokines; Allogeneic bone marrow transplantation; Graft vs. host disease; RANTES; interleukin-8

MeSH Terms

Bone Marrow Transplantation*
Bone Marrow*
Chemokine CCL5
Chemokines*
Graft vs Host Disease
Humans
Interleukin-8
Leukocytes
Lymphocytes
Macrophages
Methotrexate
Monocytes
Neutrophils
Plasma*
T-Lymphocytes
Chemokine CCL5
Chemokines
Interleukin-8
Methotrexate
Full Text Links
  • JBV
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr